Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.
Dr. Babar Khan gives opening remarks at American Delirium Society 2020 meeting

2020 event co-chaired by Regenstrief researcher scientists

More than 400 people from around the world signed up to attend the American Delirium Society’s 2020 virtual annual meeting. Presenters and participants discussed the latest in delirium research, from diagnosing the acute brain failure to strategies to reduce delirium incidence. The meeting was co-chaired by Babar Khan, M.D., M.S., Regenstrief Institute research scientist, American Delirium Society (ADS) president and Indiana University School of Medicine associate professor and Noll Campbell, PharmD, M.S., Regenstrief research scientist, ADS treasurer and Purdue College of Pharmacy assistant professor.

The annual ADS meeting was scheduled to be held in Indianapolis, but organizers moved it online in light of the COVID-19 pandemic. About three dozen experts presented keynotes and participated in abstract sessions.

More than seven million hospitalized Americans suffer from delirium each year. Delirium is a state of confusion that comes on very suddenly and can last for hours or days. It often leads to longer hospital stays, more complications, higher mortality rates, and dementia or long-term cognitive impairment. It frequently occurs in patients treated in the intensive care unit, especially those who are older than 65.

Delirium is often not diagnosed by the healthcare system, and its impact on patients’ health is often not understood. The ADS works to lead the effort to foster research, education, quality improvement, advocacy and implementation science to minimize the impact of delirium on the health and wellbeing of patients.

“Research and education about delirium is especially important during the COVID-19 pandemic,” said Dr. Khan, who served as ADS president for the 2019-2020 term. “We expect that as more COVID-19 patients are treated in the ICU, many will suffer delirium and will feel its impact in the long-term. The sharing of research and discourse during this conference will help care providers better understand this condition and provide better care for patients.”

Regenstrief Research Scientist and IU School of Medicine Assistant Professor Sikandar Khan, D.O., and IU School of Medicine Administrative Coordinator Makenna Flory assisted with managing the technology during the digital conference.

The Indianapolis ADS meeting has been rescheduled for March 2021.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 643-2313
Cindy Fox Aisen
Regenstrief Institute
caisen@regenstrief.org
(317) 843-2275

Related News

Jan 26, 2022 • News
AI models can predict individual risk of hospitalization for COVID using HIE data
Regenstrief study demonstrates how clinical data from healthcare systems can be used to better inform public health decision-making The COVID-19 pandemic has highlighted both the necessity and the difficulty of using clinical data to inform state and national public health policymaking. In a new study, Regenstrief Institute and Indiana University researchers demonstrate that machine learning…
Continue Reading >
Jan 24, 2022 • News
Local mask policy matters when it comes to public health
Findings from a new study show impact of mask mandates on behavior  Local mask policies are strong influencers on mask-wearing behavior, according to new research from Regenstrief Institute, Indiana University Richard M. Fairbanks School of Public Health and Resolve to Save Lives.   Policies requiring face masks in public have been one strategy to address the…
Continue Reading >